82 related articles for article (PubMed ID: 3003144)
1. Opioid modulation of normal and pathological human chromaffin tissue.
Mannelli M; Maggi M; DeFeo ML; Boscaro M; Opocher G; Mantero F; Baldi E; Giusti G
J Clin Endocrinol Metab; 1986 Mar; 62(3):577-82. PubMed ID: 3003144
[TBL] [Abstract][Full Text] [Related]
2. Influence of opioid antagonism on plasma catecholamines in pheochromocytoma patients.
Staessen J; Fagard R; Lijnen P; Tjandramaga TB; Verbesselt R; Amery A
J Cardiovasc Pharmacol; 1990 Mar; 15(3):386-91. PubMed ID: 1691361
[TBL] [Abstract][Full Text] [Related]
3. The lack of normal catecholamine responses in patients with pheochromocytomas.
Newsome HH
Surgery; 1983 Dec; 94(6):932-7. PubMed ID: 6648807
[TBL] [Abstract][Full Text] [Related]
4. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
Peaston RT; Lennard TW; Lai LC
J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma atrial natriuretic factor in catecholamine-producing tumor patients.
Puyó AM; Levin GM; Armando I; Donoso AS; Fernández BE; Barontini MB
Clin Exp Hypertens; 1999 Oct; 21(7):1129-44. PubMed ID: 10513832
[TBL] [Abstract][Full Text] [Related]
6. [The role of catecholamine content in human platelets; clinical implications in patients with pheochromocytoma].
Okutani R; Kono K; Fukuda T; Nakamura H; Ishida H
Masui; 1989 Nov; 38(11):1463-8. PubMed ID: 2585715
[TBL] [Abstract][Full Text] [Related]
7. Plasma beta-endorphins and catecholamines before and after clonidine in essential hypertension and pheochromocytoma.
Chodakowska J; Wocial B; Januszewicz W; Chojnowski K; Feltynowski T; Lazecki D
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S116-21. PubMed ID: 2455162
[TBL] [Abstract][Full Text] [Related]
8. Plasma catecholamine levels in the diagnosis and management of pheochromocytoma.
Hamberger B; Arnér S; Eskilsson P; Lindvall N; Werner S; Granberg PO
Surg Gynecol Obstet; 1981 Mar; 152(3):291-6. PubMed ID: 7466575
[TBL] [Abstract][Full Text] [Related]
9. Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
Bouloux PM; Grossman A; Besser GM
Clin Endocrinol (Oxf); 1986 Mar; 24(3):319-25. PubMed ID: 3708878
[TBL] [Abstract][Full Text] [Related]
10. Possible autocrine enkephalin regulation of catecholamine release in human pheochromocytoma cells.
Pellizzari EH; Barontini M; Figuerola Mde L; Cigorraga SB; Levin G
Life Sci; 2008 Sep; 83(11-12):413-20. PubMed ID: 18706432
[TBL] [Abstract][Full Text] [Related]
11. Endogenous codeine: autocrine regulator of catecholamine release from chromaffin cells.
Epple A; Nibbio B; Spector S; Brinn JE
Life Sci; 1994; 54(11):695-702. PubMed ID: 8107518
[TBL] [Abstract][Full Text] [Related]
12. [Determination of plasma catecholamine. Effects of glucagon administration].
Conte-Devolx B; Oliver C; Orlando M; Aquaron R; Giraud P; Gillioz P; Amabile G; Henry JF; Daheme D; Codaccioni JL; Serradimigni A
Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():85-9. PubMed ID: 6810834
[TBL] [Abstract][Full Text] [Related]
13. Free and conjugated plasma catecholamines in pheochromocytoma patients with and without sustained hypertension.
Puyó AM; Levin GM; Armando I; Barontini MB
Acta Endocrinol (Copenh); 1986 Sep; 113(1):111-7. PubMed ID: 3766042
[TBL] [Abstract][Full Text] [Related]
14. Clonidine suppression test for pheochromocytoma: examples of misleading results.
Taylor HC; Mayes D; Anton AH
J Clin Endocrinol Metab; 1986 Jul; 63(1):238-42. PubMed ID: 3711261
[TBL] [Abstract][Full Text] [Related]
15. Plasma atrial natriuretic factor and catecholamines before and during excision of pheochromocytoma.
Donckier JE; Michel LA; Collard E; Galanti L; Harvengt C; Berbinschi A; Ketelslegers JM; Buysschaert M
Acta Chir Belg; 1991; 91(2):112-6. PubMed ID: 1676862
[TBL] [Abstract][Full Text] [Related]
16. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.
Atuk NO; Hanks JB; Weltman J; Bogdonoff DL; Boyd DG; Vance ML
J Clin Endocrinol Metab; 1994 Dec; 79(6):1609-14. PubMed ID: 7989464
[TBL] [Abstract][Full Text] [Related]
17. Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines.
Zweifler AJ; Julius S
N Engl J Med; 1982 Apr; 306(15):890-4. PubMed ID: 7062972
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by opioid agonists and enhancement by antagonists of the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: evidence for the functional role of opioid receptors.
Kimura T; Katoh M; Satoh S
J Pharmacol Exp Ther; 1988 Mar; 244(3):1098-102. PubMed ID: 2855240
[TBL] [Abstract][Full Text] [Related]
19. Dopamine modulation of pathological human chromaffin tissue.
Mannelli M; Pupilli C; Lanzillotti R; Ianni L; Amenta F; Ricci A; Serio M
Am J Hypertens; 1990 Jun; 3(6 Pt 2):22S-24S. PubMed ID: 2143384
[TBL] [Abstract][Full Text] [Related]
20. Localization of pheochromocytoma by selective venous catheterization and assay of plasma catecholamines.
Davies RA; Patt NL; Sole MJ
Can Med Assoc J; 1979 Mar; 120(5):539-42. PubMed ID: 436033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
